Ibsrela , illustration of tablet form (not a photo of the actual pack)

Illustrative image.

Ibsrela

Tenapanor

Prescription required

$891.00

50mg · 3 × 60 tablets · 3 months supply

BrandBranded medicine

$297.00 per month

How long a supply?

1 month$297.00 a month
3 months$297.00 a month
6 months$297.00 a month
Supplied from Canada

Test mode: no payment is taken. View cart

Annual cost

$3564a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

FDA boxed warningRisk of serious dehydration in pediatric patients

IBSRELA is contraindicated in patients less than 6 years of age; in nonclinical studies in young juvenile rats administration of tenapanor caused deaths presumed to be due to dehydration.

Avoid use of IBSRELA in patients 6 years to less than 12 years of age.

The safety and effectiveness of IBSRELA have not been established in patients less than 18 years of age.

IBSRELA is contraindicated in patients less than 6 years of age; in young juvenile rats, tenapanor caused death presumed to be due to dehydration.

The safety and effectiveness of IBSRELA have not been established in pediatric patients less than 18 years of age.

Read this with the rest of the clinical information

About Ibsrela

Overview

Ibsrela is a prescription tablet containing tenapanor. It is used to treat irritable bowel syndrome with constipation (IBS-C) in adults. It works in the intestines by reducing sodium absorption, which increases water in the bowel to soften stools and help them move through more quickly.

What it treats

Irritable bowel syndrome with constipation (IBS-C) in adults.

Safety information

Side effects

Common side effects include diarrhea, abdominal bloating, gas and dizziness. Diarrhea can be severe. If severe diarrhea occurs, stop taking Ibsrela, contact your doctor and replace lost fluids.

FDA boxed warning

Risk of serious dehydration in pediatric patients

IBSRELA is contraindicated in patients less than 6 years of age; in nonclinical studies in young juvenile rats administration of tenapanor caused deaths presumed to be due to dehydration.

Avoid use of IBSRELA in patients 6 years to less than 12 years of age.

The safety and effectiveness of IBSRELA have not been established in patients less than 18 years of age.

IBSRELA is contraindicated in patients less than 6 years of age; in young juvenile rats, tenapanor caused death presumed to be due to dehydration.

The safety and effectiveness of IBSRELA have not been established in pediatric patients less than 18 years of age.

A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.

When to call your doctor

- Seek medical attention immediately if you develop severe diarrhea.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

Do not take Ibsrela if you have a known or suspected physical blockage in the stomach or intestines. It must not be used in children under 6 years of age because of the risk of serious dehydration. Ibsrela can cause severe diarrhea. If this occurs, stop taking it and seek medical advice to replace lost fluids.

Interactions

Ibsrela may reduce the amount of certain medicines absorbed into the body, including enalapril, making them less effective. Tell your doctor if you take enalapril or other medicines transported by OATP2B1. Your doctor may monitor how well these medicines are working and adjust them if needed.

Using Ibsrela

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label IBSRELA (TENAPANOR HYDROCHLORIDE) TABLET [ARDELYX, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines